AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glywohn M 1mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Riyadh Pharmaceutical

Salt Composition

Glimepiride (1mg) + Metformin (500mg)

Overview Glywohn M 1mg/500mg Tablet

Diabex Duo 1mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer Diabex Duo with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as discontinuation without medical guidance can elevate glucose levels, potentially leading to complications like kidney impairment, vision loss, neuropathy, and limb amputation. Remember, this medication complements a comprehensive treatment plan encompassing diet, exercise, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes management. Hypoglycemia (low blood sugar) is a prevalent side effect, characterized by sweating, dizziness, headache, and tremors. Learn to recognize and manage these symptoms; maintain regular meals and carry a fast-acting glucose source. Alcohol consumption elevates hypoglycemia risk and should be avoided. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also possible. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Inform your doctor of any history of heart disease before commencing treatment, as it may be unsuitable. Pregnant or lactating individuals should consult their physician prior to use. Regular blood glucose monitoring is essential, and your doctor may recommend blood tests to assess blood cell counts and liver function.

Uses of Glywohn M 1mg/500mg Tablet

Managing Type 2 Diabetes

Major Benefits of Glywohn M 1mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glywohn M 1mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.

Common Side effects of Glywohn M 1mg/500mg Tablet:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glywohn M 1mg/500mg Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Glywohn M 1mg/500mg Tablets. Ingest the tablets whole; do not crush, chew, or divide them. Administer this medication with food.

How Glywohn M 1mg/500mg Tablet works:

Glywohn M tablets (1mg/500mg) contain glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glywohn M 1mg/500mg Tablet with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glywohn M 1mg/500mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential benefits against any risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Lactation and Glywohn M 1mg/500mg tablets are incompatible; evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood glucose levels. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Glywohn M 1mg/500mg tablets, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glywohn M 1mg/500mg tablets. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Glywohn M 1mg/500mg tablets cautiously. Dosage modifications may be necessary. A physician's consultation is advised. For those with mild to moderate liver disease, Glywohn M 1mg/500mg tablets are typically initiated at a low dosage; however, their use is contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glywohn M 1mg/500mg Tablet :

Should you forget to take a Glywohn M 1mg/500mg Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Glywohn M 1mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glywohn M 1mg/500mg Tablet

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Glywohn M 1mg/500mg Tablets can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but dangerous side effect is more likely in patients with kidney disease, older adults, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glywohn M 1mg/500mg Tablets and seek immediate medical attention.
Glywohn M 1mg/500mg tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This treatment improves blood sugar control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This combination is unsuitable for type 1 diabetes.
Glywohn M 1mg/500mg tablets may cause common side effects including low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects such as lactic acidosis are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glywohn M 1mg/500mg Tablets can lead to Vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, supplemental Vitamin B12 is recommended at least annually.
Glywohn M 1mg/500mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glywohn M 1mg/500mg Tablet with alcohol is unsafe. Alcohol can exacerbate the drug's blood sugar-lowering effect, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glywohn M 1mg/500mg Table...
36
MRP 44
18% off